Embla Medical hf (LTS:0FIW) E10: kr1.12 (As of Mar. 2026)


LTS:0FIW Embla Medical hf LTS:0FIW
81 GF Score
Price kr27.20
GF Value kr34.94
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Embla Medical hf E10?

Embla Medical hf LTS:0FIW 81 E10 is kr1.12 as of Mar. 2026. GuruFocus rates LTS:0FIW with a GF Score™ of 81/100 and a GF Value™ of kr34.94 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Embla Medical hf's adjusted earnings per share data for the three months ended in Mar. 2026 was kr0.220. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr1.12 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Embla Medical hf's average E10 Growth Rate was 3.60% per year. During the past 3 years, the average E10 Growth Rate was 6.60% per year. During the past 5 years, the average E10 Growth Rate was 8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Embla Medical hf was 10.40% per year. The lowest was -29.50% per year. And the median was -9.50% per year.

As of today (2026-07-04), Embla Medical hf's current stock price is kr27.20. Embla Medical hf's E10 for the quarter that ended in Mar. 2026 was kr1.12. Embla Medical hf's Shiller PE Ratio of today is 24.29.

During the past 13 years, the highest Shiller PE Ratio of Embla Medical hf was 62.88. The lowest was 11.23. And the median was 28.70.


Embla Medical hf  (LTS:0FIW) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Embla Medical hf's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=27.20/1.12
=24.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Embla Medical hf was 62.88. The lowest was 11.23. And the median was 28.70.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Embla Medical hf E10 Related Terms


Embla Medical hf E10 Historical Data

* Premium members only.

The historical data trend for Embla Medical hf's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embla Medical hf E10 Chart

Embla Medical hf Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 0.85 1.05 1.09 1.19

Embla Medical hf Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.11 1.14 1.23 1.19 1.12

LTS:0FIW vs ABT, SYK, MDT: E10 Comparison

For the Medical Devices subindustry, Embla Medical hf's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Shiller PE Ratio falls into.


LTS:0FIW
81GF Score
Embla Medical hf LTS:0FIW
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Embla Medical hf E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Embla Medical hf's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.22/155.5573*155.5573
=0.220

Current CPI (Mar. 2026) = 155.5573.

Embla Medical hf Quarterly Data

per share eps CPI Adj_EPS
201606 0.218 101.923 0.333
201609 0.199 102.457 0.302
201612 0.233 102.562 0.353
201703 0.160 102.768 0.242
201706 0.205 103.496 0.308
201709 0.162 103.871 0.243
201712 0.333 104.481 0.496
201803 0.145 105.600 0.214
201806 0.293 106.206 0.429
201809 0.237 106.727 0.345
201812 0.518 108.388 0.743
201903 0.218 108.702 0.312
201906 0.350 109.758 0.496
201909 0.230 109.922 0.325
201912 0.232 110.588 0.326
202003 0.115 111.019 0.161
202006 -0.278 112.667 -0.384
202009 0.221 113.772 0.302
202012 0.050 114.542 0.068
202103 0.169 115.833 0.227
202106 0.284 117.451 0.376
202109 0.259 118.723 0.339
202112 0.270 120.398 0.349
202203 0.149 123.555 0.188
202206 0.239 127.809 0.291
202209 0.120 129.810 0.144
202212 0.211 131.901 0.249
202303 0.167 135.674 0.191
202306 0.261 139.150 0.292
202309 0.231 140.147 0.256
202312 0.308 142.125 0.337
202403 0.130 144.910 0.140
202406 0.326 147.267 0.344
202409 0.343 147.722 0.361
202412 0.313 148.871 0.327
202503 0.193 150.393 0.200
202506 0.323 153.367 0.328
202509 0.382 153.799 0.386
202512 0.370 155.557 0.370
202603 0.220 155.557 0.220

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of kr1.12 mean?
Embla Medical hf (LTS:0FIW) has a E10 of kr1.12 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Embla Medical hf and its competitors.
Is Embla Medical hf's E10 too high?
Embla Medical hf's current E10 is kr1.12. Overall, Embla Medical hf has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's E10 compare to ABT and SYK?
Embla Medical hf's E10 of kr1.12 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Embla Medical hf and its competitors. Embla Medical hf's current E10 is kr1.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Based on GuruFocus' analysis, Embla Medical hf (LTS:0FIW) is currently considered Modestly Undervalued. The stock's GF Value™ is kr34.94, compared to a current price of kr27.20 — trading 22.2% below its estimated fair value. The current E10 is kr1.12. Embla Medical hf's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Embla Medical hf (LTS:0FIW), the current E10 is kr1.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Embla Medical hf (LTS:0FIW) Overvalued in 2026?

Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued. The current stock price of kr27.20 is trading 22.2% below its estimated GF Value™ of kr34.94. GuruFocus considers Embla Medical hf to be Modestly Undervalued.

Key valuation signals for LTS:0FIW:

  • E10: kr1.12
  • GF Value™: kr34.94 vs. price of kr27.20 (22.2% below fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the LTS:0FIW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Embla Medical hf Business Description

Other Exchanges EMBLA:Denmark5IQ:Germany
Address Grjothals 5, Reykjavik, ISL
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
81GF Score

Get the complete analysis for LTS:0FIW

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr27.20
Price
kr34.94
GF Value